Uploaded April 2025 | Updated September 2026, 2 weeks ago
Dr. Ryan Cheu, Director of Chemistry at Emery Pharma, presents an overview of Emery Pharma’s advanced capabilities in drug metabolism, metabolite identification, and bioanalysis. This presentation was delivered during the PBSS (Pharmaceutical & BioScience Society) Workshop held on April 25, 2025, in Foster City, CA.
Topics covered include:
• Metabolite identification using LC-MS/MS, NMR, and GC-MS
• Bioanalytical services under GLP and non-GLP conditions
• Stability studies and DMPK support
• Microbiology and cell biology capabilities
• Emery Pharma’s strategic location in Alameda, CA, serving the Bay Area biotech and pharma ecosystem
Learn how Emery Pharma can be your trusted partner in solving complex analytical and regulatory challenges in drug development.
To collaborate or learn more, visit: emerypharma.com
Contact us at: info@emerypharma.com
#EmeryPharma #PBSS #DrugMetabolism #MetaboliteID #Bioanalysis #MassSpectrometry #GLP #DMPK #PharmaInnovation #BayAreaBiotech
About Emery Pharma:
As a comprehensive contract research laboratory, Emery Pharma provides extensive support across the entire spectrum of pharmaceutical development, covering small molecule drugs, biologics, biosimilars, gene therapy, botanicals, and more.
Emery Pharma's array of premium services includes analytical and bioanalytical solutions, microbiology and cell biology services, drug and impurity characterization, and comprehensive R&D with cGMP/GLP support. The Emery Pharma team excels in customizing innovative solutions tailored to the unique requirements of each client. They seamlessly oversee the entire process, from initial drug discovery to thorough data analysis and insights generation. Their expertise allows them to tackle scientific challenges proactively, ensuring clients avoid unnecessary setbacks.
Emery Pharma's accomplished chemists and biologists harness state-of-the-art technology, encompassing cutting-edge tools such as high-resolution mass spectrometry (Orbitrap), triple quad LC-MS/MS, GC-MS, preparative HPLC, and 400 MHz multinuclear NMR.
For further details, please don't hesitate to reach out to Emery Pharma at info@emerypharma.com or explore their website at:
emerypharma.com
Dr. Ryan Cheu, Director of Chemistry at Emery Pharma, presents an overview of Emery Pharma’s advanced capabilities in drug metabolism, metabolite identification, and bioanalysis. This presentation was delivered during the PBSS (Pharmaceutical & BioScience Society) Workshop held on April 25, 2025, in Foster City, CA.
Topics covered include:
• Metabolite identification using LC-MS/MS, NMR, and GC-MS
• Bioanalytical services under GLP and non-GLP conditions
• Stability studies and DMPK support
• Microbiology and cell biology capabilities
• Emery Pharma’s strategic location in Alameda, CA, serving the Bay Area biotech and pharma ecosystem
Learn how Emery Pharma can be your trusted partner in solving complex analytical and regulatory challenges in drug development.
To collaborate or learn more, visit: emerypharma.com
Contact us at: info@emerypharma.com
#EmeryPharma #PBSS #DrugMetabolism #MetaboliteID #Bioanalysis #MassSpectrometry #GLP #DMPK #PharmaInnovation #BayAreaBiotech
About Emery Pharma:
As a comprehensive contract research laboratory, Emery Pharma provides extensive support across the entire spectrum of pharmaceutical development, covering small molecule drugs, biologics, biosimilars, gene therapy, botanicals, and more.
Emery Pharma's array of premium services includes analytical and bioanalytical solutions, microbiology and cell biology services, drug and impurity characterization, and comprehensive R&D with cGMP/GLP support. The Emery Pharma team excels in customizing innovative solutions tailored to the unique requirements of each client. They seamlessly oversee the entire process, from initial drug discovery to thorough data analysis and insights generation. Their expertise allows them to tackle scientific challenges proactively, ensuring clients avoid unnecessary setbacks.
Emery Pharma's accomplished chemists and biologists harness state-of-the-art technology, encompassing cutting-edge tools such as high-resolution mass spectrometry (Orbitrap), triple quad LC-MS/MS, GC-MS, preparative HPLC, and 400 MHz multinuclear NMR.
For further details, please don't hesitate to reach out to Emery Pharma at info@emerypharma.com or explore their website at:
emerypharma.com
